Skip to content

The registry of Korean medicine treatments, including acupotomy therapy for cognitive decline

Patient Registry Study of Cognitive Impairment Patients Receiving Korean Medicine Treatment, Including Acupotomy, in Primary Clinic Settings

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009928
Enrollment
500
Registered
2024-11-15
Start date
2024-10-22
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Wonkwang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Men and women aged 55 to 85 years. 2) Individuals diagnosed with mild cognitive impairment according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, or those who do not meet the criteria for MCI but subjectively report cognitive decline. Mild cognitive impairment must be evidenced by a mild decline in one or more cognitive domains compared to previous levels. This decline can be based on concerns raised by the patient, a knowledgeable informant, or a clinician. Additionally, it must be quantitatively supported by a score of less than 23 on the Korean version of the MoCA. The cognitive decline should not interfere with the individual's ability to perform independent daily activities, nor should it occur solely in the context of delirium or be better explained by another mental disorder. 3) Individuals who have clearly understood the study and voluntarily express their intention to participate, signing the informed consent form. 4) Individuals seeking TKM treatments (acupuncture, pharmacopuncture, herbal medicine, etc.), including acupotomy, for cognitive decline.

Exclusion criteria

Exclusion criteria: 1) Individuals diagnosed with major neurocognitive disorder (dementia) according to the DSM-5 criteria. 2) Individuals who are illiterate, blind, deaf, or have severe speech disorders that make testing difficult. 3) Individuals who cannot understand Korean. 4) Individuals deemed unsuitable for participation in this clinical study at the discretion of the researcher.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment-Korean (MoCA-K)

Secondary

MeasureTime frame
Short form of Korean-Everyday Cognition (K-ECog-12);Numeric Rating Scale (NRS);Korean version of the Insomnia Severity Index (ISI-K);Korean medicine treatment;Adverse events

Countries

Korea, Republic of

Contacts

Public ContactJungtae Leem

Wonkwang University. Iksan Korean Medicine Hospital

julcho@naver.com+82-63-850-5962

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026